Indicators

Markets:

News

Latest News about LGVN

Recent news which mentions LGVN

...

4 5 6 7 8 9 10 11 Next >

Does Bone Marrow Contain The Keys To Curing Alzheimer's? BioTech Announces Promising Results From Clinical Trial

October 13, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session

October 12, 2023

12 Health Care Stocks Moving In Monday's Intraday Session

October 09, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session

October 09, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session

October 06, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session

October 05, 2023

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

October 05, 2023

Longeveron's Alzheimer's Candidate Meets Safety Goal In Mid-Stage Study

October 05, 2023

Longeveron stock jumps on Alzheimer’s trial results

October 05, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session

September 15, 2023

Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"

September 14, 2023

Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market

September 11, 2023

Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For

September 06, 2023

Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

August 31, 2023

US Stocks Rise; Initial Jobless Claims Edge Lower

August 31, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session

August 31, 2023

As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs

August 29, 2023

Earnings Scheduled For August 11, 2023

August 11, 2023

Earnings Preview: Longeveron

August 10, 2023

Longeveron – This Biotech Company Is Using The Body's Own Cells To Fight Age-Related Diseases

August 07, 2023

Longeveron Announces Key Additions To Its Leadership Team And Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions

August 07, 2023

Longeveron – Regenerative Medicine Developer Announces 100% Long Term Survival Rate For Children With HLHS

July 11, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session

July 07, 2023

HLHS Is A Rare And Serious Congenital Heart Disease With A 33% Neonatal Death Rate — Could Longeveron's Lomecel-B Improve Outcomes?

June 28, 2023

LGVN Stock Earnings: Longeveron Misses EPS, Revenue Estimates

May 12, 2023

Earnings Scheduled For May 12, 2023

May 12, 2023

Recap: Longeveron Q1 Earnings

May 12, 2023

Preview: Longeveron's Earnings

May 11, 2023

Longeveron's Lomecel-BTM Shows Encouraging Survival Data, Keeps Hypoplastic Left Heart Syndrome Pediatric Patients Heart Transplant-Free

May 09, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session

May 09, 2023

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.